V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006460 | 330010204 | 1.87 | null | Curative (C) | 2015-01-18 | 2015-01-21 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 330001965 | CISPLATIN + RT |
| 330006461 | 330003229 | 1.72 | 119 | Adjuvant (A) | 2014-04-04 | 2014-05-15 | Cisplatin + Radiotherapy | null | N | 330001965 | CISPLATIN + RT |
| 330006462 | 330003229 | 1.78 | null | Curative (C) | 2014-07-15 | 2014-07-16 | Cisplatin + Radiotherapy | N | Y | 330001965 | CISPLATIN + RT |
| 330006463 | 330003230 | 0.8 | 0 | Curative (C) | 2016-03-06 | 2016-04-04 | EW EuroEwing 2012 Arm A/B Zol Acid | Y | N | 330001982 | NOT MATCHED |
| 330006464 | 330003234 | 1.62 | null | Curative (C) | 2016-12-07 | 2016-12-07 | Cisplatin + Radiotherapy | null | Y | 330001993 | CISPLATIN + RT |
| 330006465 | 330003235 | 1.65 | 65.1 | Curative (C) | 2015-01-17 | 2015-01-21 | Cisplatin + Radiotherapy | N | N | 330001998 | CISPLATIN + RT |
| 330006466 | 330003236 | 0 | 12.6 | Neo-adjuvant (N) | 2013-08-15 | 2013-08-27 | NB Rel CCLG guidelines Irin & Temoz | N | N | 330002000 | NOT MATCHED |
| 330006467 | 330003238 | null | 11.8 | Neo-adjuvant (N) | 2016-05-19 | 2016-05-21 | NB HRNBL-1 BUMEL MAT | N | N | 330002000 | NOT MATCHED |
| 330006468 | 330003238 | 1.1 | 49 | Curative (C) | 2014-01-10 | 2014-06-20 | NB HRNBL-1 COJEC Ind COURSE C | N | Y | 330002000 | NOT MATCHED |
| 330006469 | 330003238 | null | 73 | Neo-adjuvant (N) | 2015-07-13 | 2015-07-27 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | 02 | N | 330002000 | NOT MATCHED |
| 330006470 | 330003239 | 0.02 | 91.2 | null | 2013-10-19 | 2013-10-20 | Cisplatin 100 + RT(H&N) 1 day | null | Y | 330002010 | CISPLATIN + RT |
| 330006471 | 330003240 | 1.55 | 83.6 | Curative (C) | 2013-12-15 | 2013-12-15 | CISPLATIN + RT | N | N | 330002025 | CISPLATIN + RT |
| 330006472 | 330003240 | null | 10.9 | Curative (C) | 2017-11-12 | 2017-11-18 | NB HRNBL-1 COJEC Ind COURSE C | N | N | 330002025 | NOT MATCHED |
| 330006473 | 330003242 | 0 | 60 | Curative (C) | 2013-10-10 | 2013-10-10 | CISPLATIN + RT | 02 | Y | 330002038 | CISPLATIN + RT |
| 330006474 | 330003243 | null | 11.5 | Neo-adjuvant (N) | null | 2014-04-20 | NB HRNBL-1 TVD | 02 | N | 330002043 | NOT MATCHED |
| 330006475 | 330007724 | 0 | 35.9 | Curative (C) | 2016-04-11 | 2017-03-09 | NB HRNBL-1 COJEC Ind COURSE C | N | null | 330002044 | NOT MATCHED |
| 330006476 | 330003246 | null | 78.7 | null | 2015-01-22 | 2015-01-23 | CISPLATIN + RT | N | Y | 330002045 | CISPLATIN + RT |
| 330006477 | 330003247 | 1.66 | 72 | Curative (C) | 2016-03-14 | 2016-03-14 | Cisplatin + Radiotherapy | N | Y | 330002048 | CISPLATIN + RT |
| 330006478 | 330003248 | null | null | Palliative (P) | 2014-09-23 | 2015-03-23 | NB HRNBL-1 TVD | null | null | 330002051 | NOT MATCHED |
| 330006479 | 330003251 | 1.08 | 15 | Palliative (P) | 2018-02-16 | 2018-02-23 | NB HRNBL-1 TVD | null | N | 330002055 | NOT MATCHED |
| 330006480 | 330007726 | null | 20.1 | Curative (C) | 2014-07-08 | 2014-07-08 | OST Rel Ifosfamide Etoposide Mtx | N | Y | 330002063 | NOT MATCHED |
| 330006481 | 330003253 | 0 | 17 | Neo-adjuvant (N) | 2015-04-29 | 2015-05-01 | NB HRNBL-1 BUMEL MAT | 02 | null | 330002065 | NOT MATCHED |
| 330006482 | 330003254 | 1.78 | 64.7 | null | 2013-06-04 | 2013-06-28 | Cisplatin + Radiotherapy | 02 | Y | 330002066 | CISPLATIN + RT |
| 330006483 | 330003255 | null | 82 | Curative (C) | 2015-10-02 | 2016-04-12 | CNS LGG | 01 | N | 330002068 | NOT MATCHED |
| 330006484 | 330003256 | 0 | 71.25 | Curative (C) | 2013-06-15 | 2013-06-16 | Cisplatin + Radiotherapy | N | N | 330002068 | CISPLATIN + RT |
| 330006485 | 330003260 | null | 73.4 | Curative (C) | 2016-02-15 | 2016-02-15 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330002093 | CISPLATIN + RT |
| 330006486 | 330007729 | 0 | 86.05 | Neo-adjuvant (N) | 2014-07-29 | 2014-08-20 | NB HRNBL-1 COJEC Ind COURSE C | N | N | 330002101 | NOT MATCHED |
| 330006487 | 330007730 | 1.73 | null | Curative (C) | 2016-06-28 | 2016-06-28 | CISPLATIN + RT | 02 | Y | 330002112 | CISPLATIN + RT |
| 330006488 | 330003262 | 0.96 | 18.4 | Neo-adjuvant (N) | 2013-09-12 | 2013-10-09 | NB HRNBL-1 BUMEL MAT | 02 | N | 330002114 | NOT MATCHED |
| 330006489 | 330003263 | 1.71 | 57 | Curative (C) | 2016-10-03 | 2016-10-06 | CNS LGG2004 03 vinc + carbo | N | N | 330002128 | NOT MATCHED |
| 330006490 | 330003264 | 1.59 | 69.25 | Curative (C) | null | 2015-01-13 | Cisplatin 100 + RT(H&N) 1 day | N | N | 330002128 | CISPLATIN + RT |
| 330006491 | 330003265 | null | 13.1 | Curative (C) | 2015-03-30 | 2015-04-26 | CNS PNET III Vinc, Cyclo, Etoposide | 02 | N | 330002131 | NOT MATCHED |
| 330006492 | 330007732 | null | 60.5 | Curative (C) | 2017-04-18 | 2017-04-18 | EW EuroEwing 2012 Arm A VAC | N | Y | 330002145 | NOT MATCHED |
| 330006493 | 330007732 | 1.6 | 10.4 | Curative (C) | 2011-04-25 | 2013-05-09 | NB BEACON Temozolomide alone | null | N | 330002145 | NOT MATCHED |
| 330006494 | 330003266 | 1.72 | null | Adjuvant (A) | null | 2014-08-04 | Cisplatin 100 + RT(H&N) 1 day | null | N | 330002151 | CISPLATIN + RT |
| 330006495 | 330003267 | 0.88 | 0 | Adjuvant (A) | 2015-01-24 | 2015-01-24 | NB HRNBL-1 COJEC Ind COURSE B | N | Y | 330002162 | NOT MATCHED |
| 330006496 | 330007734 | 0 | 30.6 | Neo-adjuvant (N) | 2015-03-22 | 2015-12-01 | NB HRNBL-1 COJEC Ind COURSE B | null | Y | 330002162 | NOT MATCHED |
| 330006497 | 330007735 | 1.61 | 19.2 | Disease modification (D) | 2014-01-03 | 2014-01-05 | EW EuroEwing 2012 Arm B VC | null | N | 330002177 | NOT MATCHED |
| 330006498 | 330003271 | 1.66 | 59.2 | Curative (C) | 2014-12-24 | 2014-12-28 | CISPLATIN + RT | N | N | 330002185 | CISPLATIN + RT |
| 330006499 | 330003272 | 1.77 | 56.2 | null | 2013-08-12 | 2013-10-19 | Cisplatin 100 + RT(H&N) 1 day | N | N | 330002186 | CISPLATIN + RT |
| 330006500 | 330003272 | null | 13.6 | Curative (C) | null | 2016-01-29 | NB Low/Intermed risk guidelines CADO | N | Y | 330002186 | NOT MATCHED |
| 330006503 | 330003276 | 1.81 | 92 | 2 | 2016-07-10 | 2016-09-24 | Cisplatin 100 + RT(H&N) 1 day | null | null | 330002198 | CISPLATIN + RT |
| 330006504 | 330003276 | 1.47 | 12.2 | Curative (C) | 2014-05-11 | 2014-05-24 | NB HRNBL-1 COJEC Ind COURSE C | null | null | 330002198 | NOT MATCHED |
| 330006505 | 330003279 | null | 46.4 | Curative (C) | 2017-03-07 | 2017-03-09 | NB BEACON Temozolomide Irinotecan | 02 | N | 330002205 | NOT MATCHED |
| 330006506 | 330003279 | 1.54 | 44 | Curative (C) | 2016-02-10 | 2016-02-10 | Cisplatin 100 + RT(H&N) 1 day | N | null | 330002205 | CISPLATIN + RT |
| 330006507 | 330003280 | 0.8 | 16.6 | Neo-adjuvant (N) | 2017-11-11 | 2017-11-24 | NB HRNBL-1 COJEC Ind COURSE C | null | 0 | 330002231 | NOT MATCHED |
| 330006508 | 330003282 | null | 16.1 | Curative (C) | 2016-02-24 | 2016-03-02 | Cisplatin 100 + RT(H&N) 1 day | N | null | 330002237 | CISPLATIN + RT |
| 330006509 | 330003283 | 0.97 | 11.8 | Adjuvant (A) | 2014-04-27 | 2014-05-09 | CNS GCT II Germinoma - Ifos Etop | null | N | 330002248 | NOT MATCHED |
| 330006510 | 330007743 | 1.75 | 55.5 | null | 2013-06-21 | 2013-07-07 | CISPLATIN + RT | N | Y | 330002251 | CISPLATIN + RT |
| 330006511 | 330007744 | 1.62 | null | Curative (C) | 2014-11-03 | 2014-12-20 | Cisplatin + Radiotherapy | N | Y | 330002262 | CISPLATIN + RT |